IL111017A0 - Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease - Google Patents

Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease

Info

Publication number
IL111017A0
IL111017A0 IL11101794A IL11101794A IL111017A0 IL 111017 A0 IL111017 A0 IL 111017A0 IL 11101794 A IL11101794 A IL 11101794A IL 11101794 A IL11101794 A IL 11101794A IL 111017 A0 IL111017 A0 IL 111017A0
Authority
IL
Israel
Prior art keywords
fluoroallylamine
fluorophenethyl
alzheimer
disease
treatment
Prior art date
Application number
IL11101794A
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL111017A0 publication Critical patent/IL111017A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL11101794A 1993-09-24 1994-09-21 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease IL111017A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12719093A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
IL111017A0 true IL111017A0 (en) 1994-11-28

Family

ID=22428772

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11101794A IL111017A0 (en) 1993-09-24 1994-09-21 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease

Country Status (10)

Country Link
EP (1) EP0720475A1 (en)
JP (1) JPH09505276A (en)
CN (1) CN1131390A (en)
AU (1) AU684545B2 (en)
CA (1) CA2172605A1 (en)
HU (1) HUT75877A (en)
IL (1) IL111017A0 (en)
NO (1) NO961180L (en)
WO (1) WO1995008325A1 (en)
ZA (1) ZA947262B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100479405B1 (en) * 2002-05-24 2005-03-30 주식회사 싸이제닉 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
WO2010033045A1 (en) * 2008-09-16 2010-03-25 Igor Anatolievich Pomytkin Compositions and methods for prevention or treatment of beta amyloid deposition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
AU672401B2 (en) * 1992-05-27 1996-10-03 Merrell Dow Pharmaceuticals Inc. Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatement of Alzheimer's disease

Also Published As

Publication number Publication date
HU9600725D0 (en) 1996-05-28
ZA947262B (en) 1995-05-23
CN1131390A (en) 1996-09-18
EP0720475A1 (en) 1996-07-10
WO1995008325A1 (en) 1995-03-30
HUT75877A (en) 1997-05-28
JPH09505276A (en) 1997-05-27
AU684545B2 (en) 1997-12-18
NO961180D0 (en) 1996-03-22
NO961180L (en) 1996-03-22
AU7636494A (en) 1995-04-10
CA2172605A1 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
EP0735870A4 (en) Use of pla 2? inhibitors as treatment for alzheimer's disease
HU9302551D0 (en) Compounds having effect against hypoglycemia and alzheimer's disease
GB9401176D0 (en) Device for preventing or reducing the incidence or intensity of pain in the body
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
GB2277826B (en) Surgical and/or clinical apparatus
EP1007048A4 (en) Identification of agents for use in the treatment of alzheimer's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
AU7397094A (en) Prevention and treatment of alzheimer's disease
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
IL127146A0 (en) Transdermal propentofylline compositions for the treatment of alzheimer's disease
AP9300555A0 (en) Therapeutic agent and its use
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
ITMI931181A1 (en) PROCEDURE FOR ADDITIONAL SALCICCE TREATMENT
IL111017A0 (en) Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
GB2275191B (en) Use of antifungal compounds in the treatment of skin disorders
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof
GB2284153B (en) Substances for use in treatment of HIV-infection in HIV-infected patients
ZA938836B (en) Use of inhibitors of ornithine aminotransferase in the treatment of dementia of the alzheimer's type
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
AU1455395A (en) Use of m3 muscarinic antagonists for the treatment of motion sickness
ZA951440B (en) Novel opiold peptides for the treatment of pain and use thereof